Free Trial
NASDAQ:TLIS

Talis Biomedical (TLIS) Stock Price, News & Analysis

Talis Biomedical logo
$1.70 +0.20 (+13.33%)
As of 09/4/2025 01:55 PM Eastern

About Talis Biomedical Stock (NASDAQ:TLIS)

Key Stats

Today's Range
$1.70
$1.70
50-Day Range
$1.25
$1.70
52-Week Range
$1.04
$2.20
Volume
421 shs
Average Volume
2,172 shs
Market Capitalization
$3.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Talis Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

TLIS MarketRank™: 

Talis Biomedical scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Talis Biomedical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Talis Biomedical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Talis Biomedical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Talis Biomedical has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.30% of the outstanding shares of Talis Biomedical have been sold short.
  • Short Interest Ratio / Days to Cover

    Talis Biomedical has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

  • Dividend Yield

    Talis Biomedical does not currently pay a dividend.

  • Dividend Growth

    Talis Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.30% of the outstanding shares of Talis Biomedical have been sold short.
  • Short Interest Ratio / Days to Cover

    Talis Biomedical has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Talis Biomedical this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Talis Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    46.00% of the stock of Talis Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    43.77% of the stock of Talis Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Talis Biomedical's insider trading history.
Receive TLIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TLIS Stock News Headlines

Talis Biomedical (NASDAQ:TLIS) Trading 13.3% Higher - Here's What Happened
Musk Warns. Trump Acts. Your Retirement May Depend on It
With Donald Trump back in the White House, many believe an economic revival could be underway — but it also brings new risks for retirement savers. Traditional 401(k)s and IRAs may leave investors more exposed than they realize. That’s why a Trump-backed IRS strategy is gaining attention. It allows everyday Americans to reposition their retirement savings into real assets like gold and silver — offering both protection and potential upside. A new 2025 Wealth Protection Guide explains exactly how it works.tc pixel
Talis Biomedical Corp Ordinary Shares
See More Headlines

TLIS Stock Analysis - Frequently Asked Questions

Talis Biomedical's stock was trading at $1.7590 at the beginning of the year. Since then, TLIS stock has decreased by 3.4% and is now trading at $1.70.

Talis Biomedical Co. (NASDAQ:TLIS) announced its earnings results on Tuesday, March, 15th. The company reported ($18.90) EPS for the quarter, topping the consensus estimate of ($19.20) by $0.30.

Talis Biomedical's stock reverse split on Thursday, July 6th 2023.The 1-15 reverse split was announced on Thursday, July 6th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Talis Biomedical (TLIS) raised $150 million in an initial public offering (IPO) on Friday, February 12th 2021. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, BofA Securities and Piper Sandler acted as the underwriters for the IPO and BTIG was co-manager.

Shares of TLIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Talis Biomedical investors own include Bloom Energy (BE), SoFi Technologies (SOFI), Athenex (ATNX), Alkaline Water (WTER), Milestone Scientific (MLSS), TherapeuticsMD (TXMD) and Affirm (AFRM).

Company Calendar

Last Earnings
3/15/2022
Today
9/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TLIS
CIK
1584751
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($28.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.01 million
Net Margins
N/A
Pretax Margin
-12,506.37%
Return on Equity
-79.74%
Return on Assets
-57.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.76
Quick Ratio
7.76

Sales & Book Value

Annual Sales
$300 thousand
Price / Sales
10.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$37.95 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
1,823,000
Free Float
984,000
Market Cap
$3.10 million
Optionable
No Data
Beta
1.30
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:TLIS) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners